Evidence map›Paper›PMID 19189070›Full record

ArticleJournal of molecular medicine (Berlin, Germany)2009

NF-kappaB blockade upregulates Bax, TSP-1, and TSP-2 expression in rat granulation tissue.

Daniela De Stefano, Giancarlo Nicolaus, Maria Chiara Maiuri, Daniela Cipolletta, Lorenzo Galluzzi, Maria Pia Cinelli, Gianfranco Tajana, Teresa Iuvone, Rosa Carnuccio

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of molecular medicine (Berlin, Germany), 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Cyp1B1 expression promotes angiogenesis by suppressing NF-κB activity.American journal of physiology. Cell physiology · 2013
    Article
  8. Article
  9. Thrombospondin-1: multiple paths to inflammation.Mediators of inflammation · 2011
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Daniela De StefanoDipartimento di Farmacologia Sperimentale, Facoltà di Scienze Biotecnologiche, Università degli Studi di Napoli Federico II, Via D. Montesano, 49, 80131, Naples, Italy.
Giancarlo Nicolaus
Maria Chiara Maiuri
Daniela Cipolletta
Lorenzo Galluzzi
Maria Pia Cinelli
Gianfranco Tajana
Teresa Iuvone
Rosa Carnuccio
University of Naples Federico II · ITIstituto di Genetica Molecolare · ITInserm · FRUniversity of Salerno · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Several diseases are characterized by chronic inflammation, a condition frequently associated with angiogenesis and fibrogenesis that account for the development of granulation tissue. Nuclear Factor kappa-light-chain-enhancer of activated B cells (NF-kappaB) is a crucial modulator of intracellular prosurvival signaling pathways and is implicated in the pathogenesis of inflammatory process. In this study, we have investigated the role of NF-kappaB in the angiogenic and fibrogenic response induced by lambda-carrageenin in a rat model of chronic inflammation at 1, 3, and 5 days. The subcutaneous implant of lambda-carrageenin-soaked sponges in rat induced a time-related increase of granulation tissue formation accompanied by intense neovascularization. These lambda-carrageenin-induced changes were significantly reduced by coinjection of wild-type oligodeoxynucleotide (WT ODN) decoy to NF-kappaB. Molecular, morphological, and ultrastructural analysis performed on whole granulation tissue demonstrated: (1) inhibition of NF-kappaB/DNA binding activity; (2) downregulation of cyclooxygenase-2, matrix metalloproteinase-9, tumor necrosis factor-alpha, and vascular endothelial growth factor; (3) upregulation of thrombospondin (TSP)-1 at 1 day and TSP-2 at 5 days; and (4) increase in Bax to Bcl-2 ratio. Our findings show that the blockade of NF-kappaB activation by WT ODN decoy prevents the development of granulation tissue induced by lambda-carrageenin-soaked sponge implant upregulating Bax as well as TSP-1 and TSP-2 expression.

Indexed as

Animalsbcl-2-Associated X ProteinBlotting, WesternCarrageenanCyclooxygenase 2Electrophoretic Mobility Shift AssayFibroblastsImmunohistochemistryInflammationMaleMatrix Metalloproteinase 9Microscopy, Electron, ScanningMicroscopy, Electron, TransmissionNF-kappa BOligonucleotide ProbesProtein BindingBax protein, ratbcl-2-Associated X ProteinCarrageenanCyclooxygenase 2Matrix Metalloproteinase 9NF-kappa BOligonucleotide ProbesProto-Oncogene Proteins c-bcl-2Thrombospondin 1Thrombospondin 2ThrombospondinsTumor Necrosis Factor-alphaVascular Endothelial Growth Factor A

Identifiers

PMID19189070
OpenAlexW2118737864

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.